A detailed history of Susquehanna International Group, LLP transactions in Nevro Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 88,930 shares of NVRO stock, worth $335,266. This represents 0.0% of its overall portfolio holdings.

Number of Shares
88,930
Previous 20,014 344.34%
Holding current value
$335,266
Previous $168,000 195.24%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.71 - $10.1 $324,594 - $696,051
68,916 Added 344.34%
88,930 $496,000
Q2 2024

Aug 15, 2024

BUY
$7.96 - $13.59 $36,655 - $62,581
4,605 Added 29.89%
20,014 $168,000
Q1 2024

May 07, 2024

SELL
$13.56 - $20.78 $422,855 - $648,003
-31,184 Reduced 66.93%
15,409 $222,000
Q4 2023

Feb 14, 2024

SELL
$14.18 - $22.31 $1.28 Million - $2.02 Million
-90,395 Reduced 65.99%
46,593 $1 Million
Q3 2023

Nov 14, 2023

SELL
$18.22 - $25.85 $997,198 - $1.41 Million
-54,731 Reduced 28.55%
136,988 $2.63 Million
Q2 2023

Aug 11, 2023

BUY
$22.62 - $39.32 $1.09 Million - $1.89 Million
48,134 Added 33.52%
191,719 $4.87 Million
Q1 2023

May 16, 2023

BUY
$30.17 - $41.11 $4.33 Million - $5.9 Million
143,585 New
143,585 $5.19 Million
Q3 2022

Nov 14, 2022

BUY
$40.66 - $53.03 $433,842 - $565,830
10,670 New
10,670 $497,000
Q4 2021

Feb 14, 2022

BUY
$81.07 - $121.29 $24,645 - $36,872
304 Added 8.49%
3,886 $315,000
Q3 2021

Nov 15, 2021

SELL
$101.99 - $166.36 $1.51 Million - $2.47 Million
-14,842 Reduced 80.56%
3,582 $417,000
Q2 2021

Aug 11, 2021

BUY
$141.6 - $179.06 $1.63 Million - $2.06 Million
11,496 Added 165.94%
18,424 $3.06 Million
Q1 2021

May 17, 2021

BUY
$132.81 - $182.18 $21,648 - $29,695
163 Added 2.41%
6,928 $966,000
Q4 2020

Feb 16, 2021

BUY
$138.17 - $184.34 $322,074 - $429,696
2,331 Added 52.57%
6,765 $1.17 Million
Q3 2020

Nov 16, 2020

BUY
$114.09 - $145.51 $191,214 - $243,874
1,676 Added 60.77%
4,434 $618,000
Q2 2020

Aug 14, 2020

SELL
$89.45 - $129.85 $494,211 - $717,421
-5,525 Reduced 66.7%
2,758 $329,000
Q1 2020

May 15, 2020

SELL
$70.23 - $144.31 $1.05 Million - $2.17 Million
-15,012 Reduced 64.44%
8,283 $828,000
Q3 2019

Nov 14, 2019

SELL
$61.52 - $91.1 $1.78 Million - $2.63 Million
-28,859 Reduced 55.33%
23,295 $2 Million
Q2 2019

Aug 16, 2019

BUY
$58.04 - $66.99 $372,442 - $429,874
6,417 Added 14.03%
52,154 $3.38 Million
Q2 2019

Aug 14, 2019

SELL
$58.04 - $66.99 $3.06 Million - $3.53 Million
-52,679 Reduced 53.53%
45,737 $2.97 Million
Q4 2018

Feb 14, 2019

BUY
$35.43 - $56.29 $3.19 Million - $5.07 Million
90,050 Added 1076.38%
98,416 $3.83 Million
Q3 2018

Nov 14, 2018

BUY
$44.22 - $75.47 $252,982 - $431,763
5,721 Added 216.29%
8,366 $477,000
Q2 2018

Aug 14, 2018

SELL
$72.38 - $92.5 $408,078 - $521,515
-5,638 Reduced 68.07%
2,645 $211,000
Q4 2017

Feb 14, 2018

BUY
$65.94 - $93.31 $546,181 - $772,886
8,283
8,283 $572,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.